Competitive Landscape

Browse competitive landscapes by indication. Find market opportunities and competitor mapping across all therapeutic areas.

Limited-time launch pricing

$99/month · $990/year

Save $198 - 2 months free - with yearly

Upgrade to Pro

Or explore free dashboards — PDUFA calendar, Trials Explorer, Biotechs, and more.

Competitive Landscape by Indication

Data updated: May 20, 2026

151 indications, 114,245 trials mapped

Oncology

53,941 trials

Solid Tumor (Advanced)

9364 trials 858 Ph3

Merck, Eli Lilly, Johnson & Johnson

Breast Cancer

3886 trials 697 Ph3

AstraZeneca, Roche, Pfizer

AstraZeneca, Merck, Roche

Colorectal Cancer

2540 trials 357 Ph3

AbbVie, AstraZeneca, Revolution Medicines, Inc.

Prostate Cancer

2260 trials 345 Ph3

Novartis, AstraZeneca, Jiangsu HengRui Medicine Co., Ltd.

Multiple Myeloma

1900 trials 226 Ph3

Johnson & Johnson, GSK, AbbVie

AML

1782 trials 165 Ph3

AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.

Hematologic Malignancies

1702 trials 149 Ph3

Johnson & Johnson, Novartis, Orca Biosystems, Inc.

Melanoma

1641 trials 138 Ph3

Merck, Bristol-Myers Squibb, Novartis

Pancreatic Cancer

1539 trials 133 Ph3

Revolution Medicines, Inc., AstraZeneca, Astellas Pharma Global Development, Inc.

Hepatocellular Carcinoma

1396 trials 215 Ph3

AstraZeneca, Roche, Akeso

Ovarian Cancer

1365 trials 158 Ph3

AstraZeneca, AbbVie, Merck

Lung Cancer (General)

1289 trials 166 Ph3

Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.

Head and Neck Cancer

1206 trials 111 Ph3

Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Rakuten Medical, Inc.

MDS

1170 trials 94 Ph3

Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.

Gastric Cancer

1057 trials 182 Ph3

AstraZeneca, Astellas Pharma Global Development, Inc., Chongqing Precision Biotech Co., Ltd

Sarcoma

1026 trials 72 Ph3

USWM CT, LLC, Hansoh BioMedical R&D Company, Eli Lilly

Glioblastoma

964 trials 63 Ph3

Novartis, GT Medical Technologies, Inc., Philogen S.p.A.

Bladder Cancer

959 trials 135 Ph3

Merck, AstraZeneca, Pfizer

ALL

929 trials 90 Ph3

Novartis, Amgen, Chongqing Precision Biotech Co., Ltd

Brain Tumor

781 trials 55 Ph3

Pfizer, InSightec, Jazz Pharmaceuticals

Esophageal Cancer

772 trials 130 Ph3

AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.

CLL

767 trials 82 Ph3

BeOne Medicines, Acerta Pharma BV, AbbVie

Renal Cell Carcinoma

759 trials 71 Ph3

Merck, Bristol-Myers Squibb, Exelixis

Squamous Cell Carcinoma

630 trials 62 Ph3

Regeneron, Merck, Replimune, Inc.

Triple Negative Breast Cancer

584 trials 65 Ph3

Gilead, Novartis, AstraZeneca

Cholangiocarcinoma

567 trials 58 Ph3

AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly

SCLC

548 trials 69 Ph3

Amgen, Boehringer Ingelheim, Merck

Cervical Cancer

520 trials 88 Ph3

AstraZeneca, Merck, Shanghai Bovax Biotechnology Co., Ltd.

Hodgkin Lymphoma

475 trials 36 Ph3

Merck, Takeda, Tessa Therapeutics

Endometrial Cancer

448 trials 48 Ph3

AstraZeneca, Merck, Genmab

CML

397 trials 44 Ph3

Novartis, Shenzhen TargetRx Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.

Neuroendocrine Tumors

322 trials 41 Ph3

Advanced Accelerator Applications, Crinetics Pharmaceuticals Inc., Jiangsu HengRui Medicine Co., Ltd.

Myelofibrosis

278 trials 34 Ph3

Novartis, Bristol-Myers Squibb, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Mesothelioma

275 trials 17 Ph3

Novartis, AstraZeneca, Seagen, a wholly owned subsidiary of Pfizer

Thyroid Cancer

223 trials 33 Ph3

Exelixis, Eli Lilly, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

HER2+ Breast Cancer

182 trials 31 Ph3

Sichuan Baili Pharmaceutical Co., Ltd., Roche, Jazz Pharmaceuticals

HER2- Breast Cancer

171 trials 18 Ph3

AstraZeneca, Novartis, BeOne Medicines

Merkel Cell Carcinoma

101 trials 6 Ph3

TuHURA Biosciences, Inc., ImmunityBio, Inc., AstraZeneca

CNS

10,308 trials

Major Depression

1753 trials 471 Ph3

Neurocrine Biosciences, Johnson & Johnson, Neumora Therapeutics, Inc.

Alzheimer's Disease

1507 trials 288 Ph3

Eli Lilly, Bristol-Myers Squibb, Roche

Schizophrenia

936 trials 252 Ph3

Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb

Parkinson's Disease

916 trials 171 Ph3

iRegene Therapeutics Co., Ltd., Roche, Luye Pharma Group Ltd.

Multiple Sclerosis

856 trials 233 Ph3

Roche, Novartis, Sanofi

Migraine

502 trials 191 Ph3

AbbVie, Pfizer, H. Lundbeck A/S

Epilepsy

459 trials 167 Ph3

Praxis Precision Medicines, UCB Biopharma SRL, SK Life Science, Inc.

Anxiety

457 trials 104 Ph3

VistaGen Therapeutics, Inc., Beijing Union Pharmaceutical Factory Ltd, Definium Therapeutics US, Inc.

Alcohol Use Disorder

443 trials 71 Ph3

Eli Lilly, Pop Test Oncology LLC, Newleos Therapeutics, Inc.

Opioid Use Disorder

423 trials 90 Ph3

Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Eli Lilly

ALS

343 trials 71 Ph3

Eli Lilly, Biogen, Amylyx Pharmaceuticals Inc.

Autism Spectrum Disorder

331 trials 63 Ph3

Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Curemark

ADHD

331 trials 117 Ph3

Otsuka Pharmaceutical Co., Ltd., Boehringer Ingelheim, Bazelet Nehushtan LtD.

PTSD

305 trials 61 Ph3

Oui Therapeutics, Inc., COMPASS Pathways, Senseye, Inc.

Bipolar Disorder

284 trials 94 Ph3

Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Xenon Pharmaceuticals Inc.

Neuropathy

274 trials 70 Ph3

argenx, WinSanTor, Inc, Rinri Therapeutics

Huntington's Disease

104 trials 17 Ph3

Roche, Skyhawk Therapeutics, Inc., Novartis

OCD

84 trials 11 Ph3

Vericel Corporation, Biohaven Pharmaceuticals, Inc., Roche

Infectious Disease

9,891 trials

HIV

2254 trials 440 Ph3

ViiV Healthcare, Gilead, Merck

COVID-19

2239 trials 739 Ph3

BioNTech SE, Novavax, Pfizer

Influenza

1166 trials 326 Ph3

GSK, Changchun BCHT Biotechnology Co., Sanofi

Hepatitis C

1012 trials 293 Ph3

Atea Pharmaceuticals, Inc., Gilead, Merck

Hepatitis B

620 trials 108 Ph3

Ausper Biopharma Co., Ltd., Beijing Continent Pharmaceutical Co, Ltd., GSK

Malaria

595 trials 129 Ph3

GSK, Sanaria Inc., Novartis

Sepsis

484 trials 159 Ph3

Bayer, AstraZeneca, ImmunityBio, Inc.

Tuberculosis

470 trials 115 Ph3

Shanghai Jiatan Pharmatech Co., Ltd, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc.

RSV

281 trials 68 Ph3

GSK, ModernaTX, Inc., Shenzhen Shenxin Biotechnology Co., Ltd

Fungal Infections

220 trials 68 Ph3

Merck, F2G Biotech GmbH, Basilea Pharmaceutica

H. pylori

203 trials 48 Ph3

ARJ Medical, Inc., Catalysis SL, TenNor Therapeutics (Suzhou) Limited

C. difficile

175 trials 45 Ph3

AstraZeneca, Vedanta Biosciences, Inc., Acurx Pharmaceuticals Inc.

Bacterial Infections

172 trials 35 Ph3

Pfizer, Qpex Biopharma, Inc., CanSino Biologics Inc.

Metabolic

8,800 trials

Type 2 Diabetes

2699 trials 826 Ph3

Eli Lilly, Novo Nordisk, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Obesity

1688 trials 380 Ph3

Eli Lilly, Novo Nordisk, Amgen

Diabetes (General)

1605 trials 405 Ph3

Gan & Lee Pharmaceuticals., Novo Nordisk, Jiangsu HengRui Medicine Co., Ltd.

Type 1 Diabetes

806 trials 178 Ph3

Eli Lilly, Sanofi, Novo Nordisk

Dyslipidemia

719 trials 278 Ph3

Addpharma Inc., Qilu Pharmaceutical Co., Ltd., Novartis

NASH/NAFLD

676 trials 105 Ph3

GSK, Akero Therapeutics, Inc, Corcept Therapeutics

Diabetic Complications

607 trials 137 Ph3

Roche, EyeBiotech Ltd., Regeneron

Cardiovascular

6,876 trials

Hypertension

2131 trials 622 Ph3

Boryung Pharmaceutical Co., Ltd, Addpharma Inc., Merck

Heart Failure

1181 trials 278 Ph3

Novo Nordisk, HELP Therapeutics Co., Ltd., AstraZeneca

Stroke

1137 trials 384 Ph3

Tisento Therapeutics, Shin Poong Pharmaceutical Co. Ltd., NoNO Inc.

Coronary Artery Disease

1053 trials 235 Ph3

Novartis, XyloCor Therapeutics, Inc., Beijing Inno Medicine Co., Ltd.

Myocardial Infarction

484 trials 138 Ph3

Novo Nordisk, Beijing Sungen Biomedical Technology Co., Ltd, Beijing Northland Biotech. Co., Ltd.

Atrial Fibrillation

479 trials 143 Ph3

Anthos Therapeutics, Inc., Regeneron, Novartis

Thrombosis

273 trials 119 Ph3

Regeneron, Boston Scientific Corporation, Supergene, LLC

Arrhythmia

83 trials 28 Ph3

Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals

Hypertrophic Cardiomyopathy

55 trials 18 Ph3

Shandong Suncadia Medicine Co., Ltd., Cytokinetics, Bristol-Myers Squibb

Immunology

5,001 trials

Rheumatoid Arthritis

1067 trials 288 Ph3

Eli Lilly, AstraZeneca, Bristol-Myers Squibb

Psoriasis

1019 trials 328 Ph3

Johnson & Johnson, Bristol-Myers Squibb, UCB Biopharma SRL

Atopic Dermatitis

812 trials 206 Ph3

Pfizer, AbbVie, Guangdong Hengrui Pharmaceutical Co., Ltd

Lupus

636 trials 103 Ph3

Novartis, AstraZeneca, Bristol-Myers Squibb

Crohn's Disease

524 trials 151 Ph3

Takeda, Johnson & Johnson, AbbVie

Ulcerative Colitis

522 trials 128 Ph3

Takeda, Eli Lilly, AbbVie

Psoriatic Arthritis

184 trials 80 Ph3

UCB Biopharma SRL, AbbVie, Bristol-Myers Squibb

Ankylosing Spondylitis

135 trials 45 Ph3

UCB Biopharma SRL, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Jiangsu vcare pharmaceutical technology co., LTD

IBD

102 trials 25 Ph3

Disc Medicine, Inc, iCell Gene Therapeutics, Parvus Therapeutics, Inc.

Pain

4,445 trials

Acute Pain

2754 trials 762 Ph3

Vertex Pharmaceuticals Incorporated, Eli Lilly, Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Postoperative Pain

1086 trials 235 Ph3

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Pacira Pharmaceuticals, Inc, Haisco Pharmaceutical Group Co., Ltd.

Neuropathic Pain

317 trials 53 Ph3

Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.

Chronic Pain

288 trials 74 Ph3

Evon Medics LLC, iN Therapeutics Co., Ltd., Ethos Research & Development

Respiratory

4,256 trials

Asthma

1419 trials 382 Ph3

AstraZeneca, GSK, Sanofi

COPD

1171 trials 346 Ph3

AstraZeneca, GSK, Sanofi

Pneumonia

514 trials 181 Ph3

GSK, Qilu Pharmaceutical Co., Ltd., Pfizer

Cystic Fibrosis

480 trials 132 Ph3

Vertex Pharmaceuticals Incorporated, Sionna Therapeutics Inc., Boehringer Ingelheim

Allergic Rhinitis

369 trials 137 Ph3

Genrix (Shanghai) Biopharmaceutical Co., Ltd., Prime Gene Therapeutics Co., Ltd., ALK-Abelló A/S

Idiopathic Pulmonary Fibrosis

303 trials 53 Ph3

Boehringer Ingelheim, Bristol-Myers Squibb, Sunshine Lake Pharma Co., Ltd.

Musculoskeletal

1,733 trials

Osteoarthritis

1044 trials 282 Ph3

Eli Lilly, Pacira Pharmaceuticals, Inc, TBF Genie Tissulaire

Osteoporosis

368 trials 101 Ph3

Amgen, Shenzhen Salubris Pharmaceuticals Co., Ltd., Qilu Pharmaceutical Co., Ltd.

Gout

227 trials 52 Ph3

Crystalys Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Atom Therapeutics Co., Ltd

Muscle Spasm

94 trials 45 Ph3

Chongqing Claruvis Pharmaceutical Co., Ltd., Ipsen, Merz Pharmaceuticals GmbH

Ophthalmology

1,532 trials

Age-Related Macular Degeneration

544 trials 130 Ph3

Roche, AbbVie, EyeBiotech Ltd.

Glaucoma

515 trials 146 Ph3

Glaukos Corporation, AbbVie, SpyGlass Pharma, Inc.

Dry Eye

473 trials 138 Ph3

AbbVie, Bausch & Lomb Incorporated, Laboratorios Sophia S.A de C.V.

Gastrointestinal

1,400 trials

Nausea/Vomiting

382 trials 119 Ph3

Helsinn Healthcare SA, Eli Lilly, Vanda Pharmaceuticals

Peptic Ulcer

358 trials 96 Ph3

Cellution Biologics, TR Therapeutics, Applied Biologics, LLC

Constipation

294 trials 110 Ph3

Ardelyx, Shionogi, Eli Lilly

Diarrhea

220 trials 62 Ph3

Bausch Health Americas, Inc., Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd

GERD

146 trials 45 Ph3

Cinclus Pharma Holding AB, Takeda, Addpharma Inc.

Rare Disease

1,374 trials

Sickle Cell Disease

364 trials 70 Ph3

Novartis, Forma Therapeutics, Inc., Vertex Pharmaceuticals Incorporated

Immune Thrombocytopenia

358 trials 109 Ph3

Novartis, argenx, Jiangsu HengRui Medicine Co., Ltd.

Hemophilia

287 trials 126 Ph3

Pfizer, Roche, CSL Behring

Duchenne Muscular Dystrophy

160 trials 35 Ph3

Sarepta Therapeutics, Inc., NS Pharma, Inc., Italfarmaco

Spinal Muscular Atrophy

61 trials 22 Ph3

GeneCradle Inc, Biogen, Roche

Fabry Disease

61 trials 28 Ph3

Chiesi Farmaceutici S.p.A., Amicus Therapeutics, Sanofi

Gaucher Disease

50 trials 18 Ph3

Spur Therapeutics, Prevail Therapeutics, Genzyme, a Sanofi Company

Mastocytosis

28 trials 5 Ph3

Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics

CDKL5 Deficiency Disorder

5 trials 3 Ph3

Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals

Women's Health

1,066 trials

Infertility

481 trials 162 Ph3

IBSA Institut Biochimique SA, Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas

PCOS

198 trials 59 Ph3

Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., Dexa Medica Group

Menopause

181 trials 49 Ph3

Bayer, Astellas Pharma Global Development, Inc., AbCellera Biologics Inc.

Endometriosis

159 trials 44 Ph3

AbbVie, Kissei Pharmaceutical Co., Ltd., Hope Medicine (Nanjing) Co., Ltd

Contraception

47 trials 13 Ph3

YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences

Renal

1,048 trials

Chronic Kidney Disease

833 trials 243 Ph3

AstraZeneca, Eli Lilly, Bayer

Acute Kidney Injury

215 trials 56 Ph3

Ebima Clifford Okundaye, Novartis, Arch Biopartners Inc.

Dermatology

934 trials

Acne

392 trials 112 Ph3

AbbVie, Sanofi, Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

Alopecia

251 trials 62 Ph3

Applied Biology, Inc., Veradermics, Inc., Pfizer

Rosacea

124 trials 39 Ph3

Tarsus Pharmaceuticals, Inc., Galderma R&D, LEO Pharma

Vitiligo

109 trials 31 Ph3

Incyte Corporation, Pfizer, Jiangsu HengRui Medicine Co., Ltd.

Skin Infections

58 trials 16 Ph3

GSK, Melinta Therapeutics, Inc., Durata Therapeutics Inc., an affiliate of Allergan plc

Urology

634 trials

Overactive Bladder

314 trials 89 Ph3

Levee Medical, Inc., Cook MyoSite, TBF Genie Tissulaire

Erectile Dysfunction

180 trials 53 Ph3

Aspargo Labs, Inc, EMS, Sanofi

Benign Prostatic Hyperplasia

140 trials 47 Ph3

Resurge Therapeutics Inc., Addpharma Inc., Chong Kun Dang Pharmaceutical

Hepatology

429 trials

Cirrhosis

351 trials 99 Ph3

Yaqrit Ltd, Gilead, AstraZeneca

Liver Failure

78 trials 14 Ph3

Yaqrit Ltd, eGenesis, INC, Quell Therapeutics Limited

Sleep

335 trials

Insomnia

263 trials 65 Ph3

Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Merck, Sequential Medicine Ltd

Narcolepsy

72 trials 26 Ph3

Alkermes, Inc., Takeda, Centessa Pharmaceuticals (UK) Limited

Endocrine

242 trials

Growth Hormone Deficiency

97 trials 35 Ph3

Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Xiamen Amoytop Biotech Co., Ltd.

Acromegaly

48 trials 16 Ph3

Crinetics Pharmaceuticals Inc., Debiopharm International SA, AstraZeneca

Hypothyroidism

41 trials 10 Ph3

AbbVie, IBSA Institut Biochimique SA, Neuvosyn Laboratories, LLC

Adrenal Insufficiency

30 trials 6 Ph3

Neurocrine UK Limited

Hyperthyroidism

26 trials 7 Ph3

argenx, Biohaven Therapeutics Ltd., Merida Biosciences

Click any indication to see full competitive landscape (all sponsors, trials, phases).

Data: ClinicalTrials.gov | Mapping: Indication Taxonomy